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Purpose: Surgical options for cartilage reconstruction may be signiﬁ-
cantly improved through advances in tissue engineering, whereby bioma-
terials are used to facilitate tissue repair. We have developed a cartilage
repair system, named ChonDuxTM, consisting of (1) a photopolymerized
hydrogel that promotes differentiation and cartilage formation by bone
marrow derived stem cells, and (2) a biological adhesive to secure the
hydrogel in a cartilage lesion and integrate newly formed tissue with native
tissue. We hypothesized that ChonDux could be used in conjunction with
marrow stimulation techniques to enhance the environment for cartilage
repair by endogenous stem cells. The goal of this study was to evaluate
the safety and performance of ChonDux in chondral defects in a large
animal model.
Methods: In twenty eight goats, two 6mm diameter defects were created
unilaterally on the right medial femoral condyle. Twenty goats were
treated with ChonDux. Speciﬁcally, the adhesive was applied to the
defect followed by subchondral microdrilling and ﬁlling with the hydrogel.
In eight control goats, the defects were left untreated. Animals were
cast for 2 weeks and sacriﬁced at one (n = 5), six (n = 11), and twelve
months (n = 12) post-surgery. Necropsy was performed to evaluate acute
(1 month) and long term (6 and 12 months) safety. Repair tissue was
analyzed after 6 and 12 months by histology (O’Driscoll score), histomor-
phometry (% defect ﬁll, % GAG), and immunohistochemistry for collagen
types I and II. Mechanical properties of the repair tissue in the ChonDux
group was compared to the contralateral medial condyle.
Results: The ChonDux treated group demonstrated improved cartilage
repair compared to controls after 6 months. Treated defects contained
signiﬁcantly greater ﬁll (78%) and GAG staining (53%) than control
defects (65% ﬁll, 34% GAG). O’Driscoll scores were also greater in the
ChonDux group (17.8) compared to control (14.8), though not statisti-
cally signiﬁcant (p = 0.08). At 12 months, treated defects experienced a
signiﬁcant improvement in % ﬁll (86%) and maintained O’Driscoll scores
compared to the 6 month time point. There was a decrease in % GAG
(34%) from 6 to 12 months, however staining for collagen type II was not
diminished and there was no evidence of cartilage degeneration based
on cell and tissue morphology. The control group showed lower ﬁll (81%),
lower O’Driscoll (15.9) and higher GAG (42%) compared to the treated
group, however statistically signiﬁcant differences between groups were
not found at 12 months. In control groups, histology revealed breaching of
the subchondral bone in many cases which resulted in marrow stimulation
and a variable degree of cartilage repair in this group. The repair tissue
in the ChonDux treated defects demonstrated comparable mechanical
properties to the native tissue and remained stable from 6 to 12 months.
Pathology and histopathology evaluations indicated no local or systemic
adverse responses to the implant in any of the animals.
Conclusions: Overall, this study demonstrated safety and long-term
beneﬁts of ChonDux in conjunction with marrow stimulation in a large
animal model. In particular, % ﬁll and O’Driscoll scores were consistently
higher than the controls and increased or remained stable from 6 to
12 months. Furthermore, mechanical properties were comparable to
native tissue and also remained stable from 6 to 12 months. The use of
biomaterials to guide or enhance the environment for tissue regeneration
may have an impact on clinical approaches for cartilage repair.
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Purpose: In the previous study, we revealed that the concentration-
gradient collagen gel effectively recruited the bone marrow-derived mes-
enchymal stem cells (MSCs) to the osteochondral defects in the rabbit
knee via haptotaxis, and enhanced the osteochondral repair (OARSI,
Miami, 2007). In this study, we investigated the effectiveness of timely
administration of bone morphogenetic protein-2 (BMP-2) to the MSCs
which were recruited to the defects by collagen scaffold.
Methods: The concentration-gradient collagen scaffold that we previously
reported were implanted to the full-thickness cartilage defects and recom-
binant human BMP-2 was supplied into the knee joint during one week
by osmotic pumps. Four experimental groups were assigned: BMP-2
was immediately administrated during 1 week after operation (group 1),
BMP-2 was administrated during 1 week from one week postoperatively
(group 2), and BMP-2 was administrated during 1 week from two weeks
postoperatively (group 3), and saline only (control, group 4). Rabbits were
sacriﬁced at 1, 2, 3, 4 and 8 weeks postoperatively, and Bromodeoxyuri-
dine (BrdU) positive cells were enumerated and histological grading score
were counted.
Results: Enumeration of the BrdU positive cells demonstrated that initial
BMP-2 (group 1) increased the number of proliferating cells during
the 1st week, and promoted the differentiation of the proliferating cells
during the 2nd week. The histological score of group 1 was superior as
compared with other groups at the 8 weeks postoperatively.
Conclusions: In combination with the haptotactic recruitment of the
MSCs, timely administration of BMP-2 clearly enhanced the proliferation
and differentiation of the MSCs. This spatiotemporal control of MSC
proliferation and differentiation is warranted to contribute to the successful
regeneration of the full-thickness cartilage defects.
Figure 1. BrdU positive cells at week 1.
Figure 2. BrdU positive cells at week 2.
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Purpose: Osteoarthritis (OA) is associated with advancing age and/or
traumatic intra-articular injuries. NSAIDs are commonly prescribed to help
reduce pain and improve function, but these drugs do not reverse the
degenerative changes of OA. The administration of compounds such as
glucosamine (GlcN) and chondroitin sulphate (CS) have protective effects
on chondrocytes. Although these compounds enhance extracellular ma-
trix (ECM) production by healthy chondrocytes, it is still unclear what their
effect is on OA chondrocytes.
The aim of this study was to determine whether GlcN has a beneﬁcial
effect on OA chondrocytes when cultured in vitro in 3D hydrogels. The
inﬂammatory response and ECM formation capacity of OA chondrocytes
were investigated with varying GlcN concentration. An in vivo OA model
was developed in rats to detect degenerative changes at 4 and 8 weeks.
